4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-007406
Chief Executive Officer sold 9,500 shares at $0.67 ($6,369)
From the SEC's structured data for this filing
Trades in this filing
Brainard Diana · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-23 | Sale : show line 1 in the form | −9,500 | $0.67 | $6,369 | 863,742 | D |
| Open-market sales · 9,500 sh · avg $0.67 · $6,369 | ||||||
Loading xslF345X05/ownership.xml…